Precision medicine

May 1, 2024
Woman patient speaking with doctor
May 1, 2024
Categories

NCCN Recommends Universal Testing for Microsatellite Instability by PCR/NGS or Mismatch Repair by IHC for All Newly Diagnosed Gastric Cancer Patients

EA2212 is a randomized phase 2 study assessing if chemotherapy plus immunotherapy is superior to immunotherapy alone for patients with operable MSI-H/dMMR gastric and/or gastroesophageal junction cancer
Do you like it?
0 Read more
October 19, 2023
MATCH graphic
October 19, 2023
Categories

It’s a MATCH: Peter O’Dwyer on the Future of Precision Oncology

Following the recent Nature Medicine publication of lessons from the NCI-MATCH trial, two new podcasts discuss the pitfalls and promises of precision oncology—and opportunities to guide the field as it moves forward
Do you like it?
0 Read more
April 19, 2023
ComboMATCH image
April 19, 2023
Categories

Now Enrolling: ECOG-ACRIN Opens the ComboMATCH Patient Registration Trial as the Gateway to a Coordinated Set of Treatment Trials

ComboMATCH researchers are discovering new drug combinations that show promise for patients with advanced cancers, based on strong pre-clinical in vivo evidence of therapeutic effectiveness
Do you like it?
0 Read more
December 20, 2022
Woman talking with doctor
December 20, 2022
Categories

Trial Spotlight: Robert Ferris and Christine Chung on the EA3132 Trial for Patients With Head and Neck Cancer

This phase 2 study is examining whether the addition of cisplatin to PORT will provide a survival benefit to certain patients with stage 3/4 squamous cell carcinoma of the head and neck
Do you like it?
0 Read more
April 15, 2022
Doctor patient talking
April 15, 2022
Categories

Trial Spotlight: Nadine Tung on the EA1181/CompassHER2 pCR Trial for HER2-Positive Breast Cancer

This study aims to determine if it is safe to omit adjuvant chemotherapy after surgery for patients with pathologic complete response (pCR) after 12 weeks of pre-operative treatment
Do you like it?
0 Read more
123